NCT07521410

Brief Summary

The goal of this randomized controlled clinical trial is to learn whether different non-invasive ventilation interfaces can prevent medical device-related nasal pressure injury in preterm infants receiving respiratory support in a neonatal intensive care unit. The main questions it aims to answer are:

  • Do different non-invasive ventilation interfaces affect how often nasal pressure injury develops?
  • Do these interfaces affect the severity of nasal pressure injury and the condition of the nasal skin? Researchers will compare three types of non-invasive ventilation interfaces (binasal prong, nasal cannula, and nasal mask) to see if one method is more effective in reducing nasal pressure injury. Participants will:
  • Be randomly assigned to one of three groups (binasal prong, nasal cannula, or nasal mask)
  • Receive non-invasive ventilation support using the assigned interface for at least 4 days
  • Have their nasal skin assessed every 12 hours for 96 hours using standardized scales
  • Continue to receive routine care in the neonatal intensive care unit

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Apr 2026Oct 2026

First Submitted

Initial submission to the registry

April 3, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 9, 2026

Completed
11 days until next milestone

Study Start

First participant enrolled

April 20, 2026

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 24, 2026

Expected
Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

4 days

First QC Date

April 3, 2026

Last Update Submit

April 13, 2026

Conditions

Keywords

Preterm infantsNon-invasive ventilationNasal pressure injuryMedical device-related pressure injuryNeonatal intensive care unitCPAPNasal interface

Outcome Measures

Primary Outcomes (1)

  • Incidence of Medical Device-Related Nasal Pressure Injury

    Occurrence of medical device-related nasal pressure injury in preterm infants receiving non-invasive ventilation, assessed using a standardized pressure injury staging scale.

    Within 96 hours (4 days) after initiation of non-invasive ventilation

Secondary Outcomes (3)

  • Severity of Nasal Pressure Injury

    Every 12 hours for 96 hours

  • Nasal Skin Condition

    Every 12 hours for 96 hours

  • Risk of Skin Injury

    Every 12 hours for 96 hours

Study Arms (3)

Binasal Prong

EXPERIMENTAL

Preterm infants receiving non-invasive ventilation support via binasal prong interface.

Device: Binasal Prong

Nasal Cannula

EXPERIMENTAL

Preterm infants receiving non-invasive ventilation support via nasal cannula interface.

Device: Nasal Cannula

Nasal Mask

EXPERIMENTAL

Preterm infants receiving non-invasive ventilation support via nasal mask interface.

Device: Nasal Mask

Interventions

Continuous positive airway pressure (CPAP) delivered via binasal prong interface.

Binasal Prong

Continuous positive airway pressure (CPAP) delivered via nasal cannula.

Nasal Cannula

Continuous positive airway pressure (CPAP) delivered via nasal mask interface.

Nasal Mask

Eligibility Criteria

Age0 Minutes - 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants with a gestational age between 28 and 37 weeks
  • Receiving non-invasive ventilation support in a neonatal intensive care unit
  • Receiving non-invasive ventilation for at least 4 days
  • Parental consent obtained

You may not qualify if:

  • Infants requiring intubation
  • Presence of congenital anomalies
  • Pre-existing nasal injury or trauma
  • Presence of skin disease
  • Nasal lesions due to previous nasotracheal intubation
  • Upper airway malformations
  • Infants transferred from another center after receiving more than 24 hours of non-invasive ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tekirdag Ismail Fehmi Cumalioglu City Hospital, Neonatal Intensive Care Unit

Tekirdağ, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Premature Birth

Interventions

Cannula

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

CathetersEquipment and Supplies

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Outcome assessments will be performed by the responsible researcher and an independent neonatal intensive care unit charge nurse. Because the intervention assignment is known during assessment, the study is open label.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of three parallel groups (binasal prong, nasal cannula, or nasal mask) to compare their effects on the development of nasal pressure injury in preterm infants receiving non-invasive ventilation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 3, 2026

First Posted

April 9, 2026

Study Start

April 20, 2026

Primary Completion

April 24, 2026

Study Completion (Estimated)

October 24, 2026

Last Updated

April 16, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to ethical and legal restrictions regarding the confidentiality of neonatal patient data and institutional policies.

Locations